Ocrelizumab quantitation by liquid chromatography-tandem mass spectrometry

INTRODUCTION: Ocrelizumab is a monoclonal anti-CD20 antibody approved for the treatment of multiple sclerosis (MS). The clinical value of therapeutic drug monitoring (TDM) for this antibody in treatment of MS is unknown, and an adequately specific and precise quantitation method for ocrelizumab in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Hallin, Erik I., Trætteberg Serkland, Trond, Myhr, Kjell-Morten, Grytten Torkildsen, Øivind, Skrede, Silje
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334332/
https://www.ncbi.nlm.nih.gov/pubmed/35910410
http://dx.doi.org/10.1016/j.jmsacl.2022.07.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334332/
https://www.ncbi.nlm.nih.gov/pubmed/35910410
http://dx.doi.org/10.1016/j.jmsacl.2022.07.004

Ejemplares similares